Clinical Trials Browser

Interferon-alpha × Dermatologic × 90 days × Clear all

NCT00003641 2026-02-25

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Phase 3 Active not recruiting

1,150 enrolled 6 charts

Melanoma